Manufacturer record
Laborate Pharmaceutical India Ltd. 111: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Laborate Pharmaceutical India Ltd. 111 (Himachal Pradesh) were declared Not of Standard Quality in July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: OPZDC4059, Omerprazole Capsules I.P 20 mg. (exp Oct 2026). RDTL, Bellary Karnataka (state lab) found it not of standard quality: Test for Dissolution for Omeprazole both at Acid and Buffer Stage. Listed in the July 2026 alert.
Records by type
2 records linked to Laborate Pharmaceutical India Ltd. 111 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Omerprazole Capsules I.P 20 mg. | Batch OPZDC4059Mfg Nov 2024 · Exp Oct 2026 | Test for Dissolution for Omeprazole both at Acid and Buffer StageDissolution | RDTL, Bellary KarnatakaState lab | Jul 2026 |
| Diclofenac Sodium Injection I.P. | Batch ZYCD15018Mfg Oct 2025 · Exp Sep 2027 | Content of Diclofenac SodiumOther | KANPUR LAB, UPState lab | Jul 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.